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BACKGROUND. Lung cancer incidence rates among American Indians and Alaska
Natives (AI/ANs) in the United States have not been described well, primarily
because of race misclassification and, until the 1990s, incomplete coverage of
their population by cancer registries. Smoking, the predominant cause of lung
cancer, is particularly prevalent among this population.
METHODS. Data from the National Program of Cancer Registries and the Surveil-
lance, Epidemiology, and End Results Program were combined to estimate age-
adjusted incidence rates of lung cancer during 1999 through 2004. Cases were linked
to Indian Health Service (IHS) registration databases to identify AI/ANs whose race
may have been misclassified. Age-adjusted rates were calculated for Contract Health
Service Delivery Area (CHSDA) counties and for all counties by IHS region, and
comparisons were made between AI/ANs and non-Hispanic whites (NHWs).
RESULTS. Among populations living in CHSDA counties, NHWs overall had
higher rates of lung cancer than AI/ANs. However, the rates (per 100,000 popula-
tion) among AI/ANs varied substantially between IHS regions from 14.9 (South-
west) to 87.1 (Southern Plains), 93.2 (Alaska), and 104.3 (Northern Plains).
Approximately 41.6% of AI/AN lung cancer cases were diagnosed before age 65
years compared with approximately 29.8% of NHW lung cancer cases. The overall
percentage stage distribution was not different between AI/ANs and NHWs.
Squamous cell carcinomas were slightly more common and adenocarcinomas
were less common among AI/ANs than among NHWs. Lung cancer rates were
not decreasing for AI/ANs as they were for NHWs.
CONCLUSIONS. Data from this study clarified the need for culturally appropriate
tobacco prevention and control policies and resources for AI/ANs in all regions,
and especially in the Plains and Alaska. Cancer 2008;113(5 suppl):1168–78.
Published 2008 by the American Cancer Society.*
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I n the United States, lung cancer is the most fre-quently diagnosed invasive cancer. Because it is
difficult to treat, it is also the leading cause of cancer
deaths, accounting for approximately 158,000 deaths
each year in the United States.1 Although this can-
cer occurs throughout the United States population,
incidence rates vary considerably between racial
and ethnic populations, particularly because of the
variations in tobacco use across the United States.
Cigarette smoking is the most important cause of
lung cancer, accounting for 90% of lung cancer
deaths in males and 75%-80% of lung cancer deaths
in females in the United States.2-4 Exposure to other
risk factors for lung cancer, such as asbestos,
naturally occurring radon gas in homes, and an
occupational history of uranium mining, also are
contributors.1,5-12
Several studies have demonstrated that AI/AN
cancer incidence historically has been underre-
ported with the result that the burden of cancer
in this population has been described inaccu-
rately.13-16 This underreporting has 2 sources: First,
AI/AN cancer incidence rates reported in the Sur-
veillance, Epidemiology, and End Results (SEER)
data were dominated by the large AI population
ascertained by the New Mexico Tumor Registry
(NMTR), which is one of the original SEER cancer
registries, and often were cited as representative of
all AI/AN populations in the United States. How-
ever, lung cancer incidence rates in the Southwes-
tern AI population, as reflected in the NMTR data,
are much lower than in other regions.17 A second
source of the underreporting is that the race of AI/
ANs often is misclassified in medical records, vital
statistics, cancer registries, and other databases.
Linking state cancer registry data with Indian
Health Service (IHS) patient registration informa-
tion can correct some underreporting because of
the misclassification of race. In previous linkage
studies, AI/AN mortality and incidence rates in
some locations have doubled subsequent to such
linkages.18,19
The objective of this study was to reduce the
misclassification of AI/AN race through linkages
with analyses restricted to the IHS Contract Health
Services Delivery Area (CHSDA) counties, where a
larger percent of the population is AI/AN and mis-
classification of AI/AN race is believed to be lower
than in other counties.20 The cancer data used in
this study are from population-based cancer regis-
tries across the United States and thereby provide
an opportunity to present a more complete picture
of lung cancer incidence in regional AI/AN popula-
tions.
MATERIALS AND METHODS
Case Identification
The cancer incidence data for this study were
obtained from state and regional cancer registries
throughout the United States for cases diagnosed
during 1999 through 2004. All of these registries par-
ticipate in either the Centers for Disease Control and
Prevention’s (CDC) National Program of Cancer
Registries (NPCR) or the National Cancer Institute’s
(NCI) SEER Program,21 or both. Data were included
from those registries that agreed to participate and
met the United States Cancer Statistics standards for
high-quality data.21 Only 4 states were excluded from
the analysis: Kansas, Maryland, South Carolina, and
Vermont. Primary cancer site and histology data
were coded according to the International Classifica-
tion of Diseases for Oncology (ICD-O) edition in that
was use at the time of diagnosis and are converted
to the third edition.22 Invasive lung cancer cases
were identified with the ICD-O version 3 codes C340
through C349.22 Histologies that involved hematopoi-
etic diseases, mesothelioma, and Kaposi sarcoma
were excluded (M9590-9989, 9050-9055, and 9140).
For 1999 through 2000, SEER Summary Stage 1977
was used; for 2001 through 2003, SEER Summary
Stage 2000 was used; and, for 2004, collaborative
stage was coded, but the data were not available for
analysis. For this study, stage data for 2001 through
2003 only are presented because of differences
observed in comparative analyses of the 2 SEER
Summary Stage systems.23,24 Cell types were classi-
fied as adenocarcinoma (M8140-8389, 8401, 8408,
8410-8411, 8413, 8441, 8450, 8460, 8470, 8480-8482,
8490, 8500, 8503-8504, 8510, 8520, 8525, 8530, 8560,
8571-8574, 8576, 9070, and 9110), squamous cell car-
cinoma (M8050-8071, 8074-8089, and 8094), small
cell carcinoma (M8041, 8044, and 8073), and large
cell carcinoma (M8012-8014, 8045, and 8072).25
To obtain the most accurate race information,
states worked with the IHS to link cancer registry
databases with IHS patient registration data. This
linkage effectively identified those individuals who
may not have been classified as AI/AN in the state
cancer registries but were known to be members of
federally recognized tribes and enrolled in the IHS
healthcare system. If an individual was not identified
as AI/AN in the cancer registry but was identified as
AI/AN in the IHS database, then the individual was
classified as AI/AN for this analysis. For more details
about the linkage methodology, see the report by
Espey et al in this supplement to Cancer.26 Hispanic
origin was identified for all individuals in the registry
databases using the North American Association of
Central Cancer Registry Hispanic Identification Algo-
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rithm.27 Individuals who were included in the AI/AN
race category were included regardless of Hispanic
origin. For all analyses, AI/ANs were compared with
NHWs.
Population Estimates, Regional Definitions, and
Geographic Coverage
County level annual population estimates for the
years 1999 through 2004 were modified in 2 ways to
be used in the denominators of the rate calculations.
First, since 2000, the population estimates from the
US Bureau of the Census have included data from
individuals who identify themselves as belonging to
more than 1 racial group. The CDC National Center
for Health Statistics collaborated with the Bureau of
the Census to develop methods for converting the
multiple race data collected into single race cate-
gories.28 Second, the NCI provided additional refine-
ments to race and county codes for use in the
SEER*Stat software program.29,30 To assess regional
variation in incidence, the states were grouped into 6
previously developed IHS regions (Fig. 1).26 The ‘all-
counties’ incidence rates, for which no geographic
restrictions apply, included data from registries in 46
states and the District of Columbia. For most tabula-
tions, however, the analyses were restricted to ‘Con-
tract Health Service Delivery Area’ (CHSDA) counties,
which, in general, contain federally recognized tribal
lands or are adjacent to tribal lands (Fig. 1). For inci-
dence rates restricted to CHSDA counties, data from
33 registries were included. Restricting the analysis
to CHSDA counties was another method used to
minimize racial misclassification.26 Approximately
56% of the United States AI/AN population resides in
CHSDA counties. This proportion varies by IHS
region (Alaska, 100%; East, 13.1%; Northern Plains,
59%; Southern Plains, 64.1%; Pacific Coast, 55.6%;
Southwest, 87.5%).
Statistical Analysis
Age-adjusted lung cancer incidence rates, expressed
as the number of cases per 100,000 population and
age-adjusted by 19 age groups to the 2000 United
States standard population, were calculated for AI/
AN and NHW populations using SEER*Stat software
version 6.3.6.30 Percent distributions for stage and
histology also were age-adjusted to the same stand-
ard population. For all analyses, exact counts were
suppressed when the category of interest contained
<6 cases.
By using the age-adjusted incidence rates, stan-
dardized rate ratios (RRs) were calculated for AI/AN
populations using NHW rates for comparison. Confi-
dence intervals (CIs) for age-adjusted rates and stan-
dardized RRs were calculated based on methods
described by Tiwari et al31 using SEER*Stat 6.3.6.30
FIGURE 1. States and Contract Health Service Delivery Areas (CHSDA) counties by Indian Health Service region are illustrated.
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An RR >1.0 indicated that the AI/AN rate was greater
than the NHW rate. Similarly, an RR <1.0 indicated
an AI/AN rate less than the NHW rate. The annual
percentage change (APC) was calculated for both AI/
AN and NHW lung cancer incidence rates to assess
trends during 1999 through 2004 (P<.05). Percentage
changes were calculated using 2 years for each end-
point, and the APC was not calculated if it was based
on fewer than 10 cases for at least 1 year within the
time interval.
RESULTS
Lung cancer incidence rates in CHSDA counties var-
ied nearly 7-fold for AI/ANs across IHS regions in the
United States (Table 1). Among AI/ANs, rates were
highest in the Northern Plains (104.3), Alaska (93.2),
and the Southern Plains (87.1) and lowest in the
Southwest (14.9). This same pattern was observed in
the analysis of all counties combined, although the
rates were lower and the variation was nearly 5-fold.
Lung cancer incidence rates for NHWs did not ex-
hibit the same magnitude of variation or the same
pattern of regional variation; in the CHSDA counties,
NHW rates were highest in the Southern Plains (82.2)
and the East (74.2). All subsequent presentations of
data refer to CHSDA county data unless noted other-
wise.
Among the populations living in CHSDA coun-
ties, AI/ANs had significantly higher rates (P < .05) of
lung cancer than NHWs for both males and females
in the Northern Plains and Alaska and for females in
the Southern Plains (Table 1). In the Southern Plains,
AI/AN males had lung cancer incidence rates that
were approximately the same as those for NHWs,
although that rate was significantly higher than the
national NHW rate. In contrast, incidence rates for
AI/ANs in the Pacific Coast, East, and Southwest
regions all were significantly lower than the rates for
NHWs in the same regions for both males and
females (Table 1, Fig. 2).32 From 1999 through 2004,
male NHW lung cancer incidence rates decreased
significantly for all regions combined, whereas male
AI/AN rates remained approximately level (Table 2).
Over the same period, rates among AI/AN females
and NHW females did not change.
The highest rates among AI/ANs for each age
group were in the Northern Plains, Alaska, and the
Southern Plains (Table 3). Similar regional patterns
were not observed for NHWs, and their highest rates
were observed among those living in the Southern
Plains and the East. Like for many other forms of
cancer, rates increased with age, and the highest
rates occurred in the oldest age group (aged
65 years). Among individuals aged 50 years, lung
cancer incidence rates were significantly higher
among AI/ANs than among NHWs in the Northern
Plains and Alaska. Also, among individuals aged 50
years, the rates were significantly lower among AI/
ANs than among NHWs in the Southwest, East, and
Pacific Coast regions. AI/ANs were diagnosed with
lung cancer at younger ages than NHWs. Among AI/
ANs, 58.5% of cases were aged 65 years at diagnosis
compared with 70.2% of cases among NHWs.
Table 4 displays an analysis of the lung cancer
incidence by disease stage at diagnosis among AI/
ANs and NHWs for CHSDA counties in the 6 IHS
regions. For both populations across all regions,
approximately 44% of cases were diagnosed at a dis-
tant stage. In the Southwest, AI/ANs had the highest
percentage of distant-stage disease (53.3%) and the
lowest percentage of local-stage disease (11.3%).
Although AI/ANs in the Southern Plains had among
the higher lung cancer incidence rates, AI/ANs in the
same region had the lowest percentage of cases diag-
nosed with distant-stage disease (40.5%). For all
regions combined, AI/AN females were more likely
than AI/AN males to have their lung cancer diag-
nosed at a local stage and to have less distant-stage
disease (data not shown). Among NHWs, the highest
proportion of distant-stage disease was observed in
the Pacific Coast and Alaska regions; the percentage
stage distributions did not differ appreciably by sex
(data not shown).
A comparison of the percentage distribution of
histologic type among microscopically confirmed
lung and bronchus cancer in cases between AI/ANs
and NHWs in CHSDA counties is presented in Table
5. For all regions combined, AI/ANs had relatively
less adenocarcinoma (29.2%) and slightly more squa-
mous cell histology (24.0%) than NHWs (37.1% and
20.4%, respectively), except in the Southern Plains
and Southwest, where the histology distributions for
the 2 populations were similar.
DISCUSSION
This is the most comprehensive study of the inci-
dence of lung cancer among the AI/AN populations
in the United States to date. Combining NPCR and
SEER data for broad population coverage and using
linkages to improve on the misclassification of race
among AI/ANs provided the opportunity to describe
both regional and national estimates of lung cancer
incidence for AI/ANs. Our findings confirmed the
dramatic regional differences in lung cancer rates
that have been reported in studies using death certi-
ficates.16 Lung cancer incidence rates in AI/ANs var-
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ied 7-fold across IHS regions (in CHSDA counties),
with the highest rates observed in the Northern and
Southern Plains and Alaska and the lowest rates
observed in the Southwest. AI/AN males and females
were diagnosed with lung cancer at a younger age
than NHWs, but the distribution of disease stage did
not differ between the 2 populations. Adenocarci-
noma was less common and squamous cell histology
was slightly more common among AI/ANs than
among NHWs.
Cigarette smoking and exposure to environmen-
tal tobacco have been linked directly to lung cancer
and many other diseases, including heart disease,
stroke, and multiple cancers,2,3,33 that translate into
multibillion dollar medical and lost productivity
costs in the United States.34 AI/ANs have the highest
prevalence of daily cigarette use of any population in
the United States.35 The prevalence of tobacco use
varies greatly among AI/ANs by region.36 Thus, re-
gional lung cancer rates also can be expected to
vary; and, similar to the current study, such varia-
tions were observed in earlier incidence and mortal-
ity studies.13-16,37
Tobacco use survey information must be inter-
preted with caution, because many American Indians
use tobacco for traditional or ceremonial purposes
and may or may not also be habitual smokers.38,39
Tobacco has been a key element in the ceremonial
practices of many American Indian people from pre-
FIGURE 2. Lung and bronchus cancer incidence rates for American Indians and Alaska Natives (AI/AN) and non-Hispanic whites (NHW) by Indian Health Ser-
vice (IHS) region and Sex in Contract Health Service Delivery Area (CHSDA) counties in the United States from 1999 to 2004. aRates are age-adjusted to 2000
United States standard population (19 age groups; Census P25-1130; see Day, 199632). N Plains indicates Northern Plains; S Plains, Southern Plains. Source:
cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance,
Epidemiology, and End Results Program.
TABLE 2
Invasive Lung and Bronchus Cancer Incidence Annual Percentage
Change by Year of Diagnosis and Indian Health Service Region for
American Indians/Alaska Natives and Non-Hispanic Whites in
ContractHealth ServiceDelivery Area Counties: United States, 1999-2004
Both Sexes Males Females
IHS Region
AI/AN
APC
NHW
APC
AI/AN
APC
NHW
APC
AI/AN
APC
NHW
APC
Northern Plains 24.5 20.5 23.1 20.9 25.9 20.1
Alaska 5.6 22.6 2.0 20.7 10.8 25.2
Southern Plains 1.6 20.7 2.1 22.2 0.2 1.1
Pacific Coast 0.9 21.8a 2.6 22.8a 0.0 20.8a
East 210.8 20.8a 216.0a 21.8a 28.2 0.2
Southwest 25.1 21.1 22.8 22.1a 27.5 20.1
Total 20.2 21.2a 0.1 22.1a 20.6 20.3
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of
Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results
Program.
IHS indicates Indian Health Service; AI/AN, American Indians/Alaska Natives; APC, annual percent-
age change; NHW, non-Hispanic whites.
a The APC is significantly different from zero (P<.05).
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TABLE 4
Invasive Lung and Bronchus Cancer Incidence, Percentage Distribution by Summary Stage and Indian Health Service Region for American
Indians and Alaska Natives and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: United States, 1999-2003a
Localized Regional Distant Unstaged
IHS Region Count Rateb 95% CI
% of
Casesc Count Rateb 95% CI
% of
Casesc Count Rateb 95% CI
% of
Casesc Count Rateb 95% CI
% of
Casesc
AI/AN
Northern Plains 64 17.4 13.2-22.4 16.8 109 26.3 21.4-32.0 25.4 170 44.4 37.6-51.9 42.9 45 15.3 11.0-20.5 14.8
Alaska 24 13.3 8.3-19.9 14.4 43 24.0 17.2-32.5 25.9 79 41.8 32.7-52.4 45.1 19 13.6 8.0-21.0 14.7
Southern Plains 98 14.9 12.1-18.2 17.0 135 20.0 16.7-23.7 22.9 239 35.4 30.9-40.2 40.5 106 17.1 14.0-20.8 19.6
Pacific Coast 50 8.1 5.9-10.8 14.4 72 12.1 9.3-15.4 21.5 169 28.1 23.7-32.9 49.9 41 8.1 5.7-11.0 14.4
East 16 10.0 5.6-16.2 19.4 19 11.4 6.7-18.0 22.1 33 21.4 14.5-30.2 41.5 11 8.7 4.3-15.3 16.9
Southwest 15 1.7 0.9-2.9 11.3 21 2.4 1.4-3.6 16.0 65 8.0 6.1-10.2 53.3 25 3.0 1.9-4.4 20.0
Total 267 9.4 8.3-10.6 16.0 399 13.5 12.2-15.0 22.9 755 26.2 24.2-28.2 44.5 247 9.8 8.6-11.2 16.6
NHW
Northern Plains 3156 12.1 11.7-12.6 18.4 4345 16.7 16.2-17.2 25.4 6864 26.4 25.8-27.0 40.2 2786 10.4 10.0-10.8 15.8
Alaska 95 11.2 8.9-13.8 15.6 141 15.7 13.0-18.7 21.8 318 34.1 30.1-38.4 47.4 83 11.1 8.7-13.8 15.4
Southern Plains 1535 15.1 14.3-15.8 18.1 1995 19.7 18.8-20.5 23.6 3513 34.7 33.6-35.9 41.6 1438 14.1 13.4-14.8 16.9
Pacific Coast 5386 11.4 11.1-11.7 16.4 7679 16.3 15.9-16.6 23.4 16,529 34.9 34.3-35.4 50.1 3414 7.0 6.8-7.3 10.1
East 4315 12.7 12.4-13.1 17.2 5655 16.9 16.4-17.3 22.8 10,823 32.1 31.5-32.7 43.4 4331 12.3 11.9-12.7 16.6
Southwest 2219 9.9 9.5-10.3 14.9 2747 12.3 11.8-12.7 18.6 5,900 26.5 25.8-27.2 40.0 3956 17.7 17.1-18.2 26.7
Total 16,706 11.9 11.7-12.1 16.9 22,562 16.1 15.9-16.3 22.9 43,947 31.2 31.0-31.5 44.3 16,008 11.1 11.0-11.3 15.8
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER)
Program.
IHS indicates Indian Health Service; CI, confidence interval; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites.
a SEER Summary Stage 2000 was used.
b Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups; Census P25-1130; see Day 199632).
c Percentages are age-adjusted to the 2000 U.S. standard population; percentages may not add to 100% because of rounding.
TABLE 3
Invasive Lung and Bronchus Cancer Incidence Rates by Age and Indian Health Service Region for American Indians and Alaska Natives and
Non-Hispanic Whites in Contract Health Service Delivery Area Counties: United States, 1999-2004
<50 Years 50-64 Years ‡65 Years
IHS Region Count % of Casesa Rateb 95% CI Count % of Casesa Rateb 95% CI Count % of Casesa Rateb 95% CI
AI/AN
Northern Plains 48 6.7 5.6 4.1-7.4 261 36.3 179.3c 158.2-202.4 410 57.0 580.8c 524.2-641.9
Alaska 19 5.8 4.6 2.8-7.1 113 34.7 163.2c 134.4-196.2 194 59.5 517.0c 445.0-597.5
Southern Plains 107 9.5 8.9 7.3-10.7 376 33.2 157.4 141.9-174.1 648 57.3 451.3 416.9-487.8
Pacific Coast 30 5.0 2.0d 1.3-2.8 221 36.5 83.6d 72.9-95.4 354 58.5 299.4d 268.2-333.2
East 13 9.0 3.6 1.9-6.1 46 31.9 72.8d 53.2-97.0 85 59.0 263.3d 209.6-326.7
Southwest 13 5.4 0.6d 0.3-1.1 68 28.3 20.9d 16.2-26.5 159 66.3 89.7d 76.1-105.0
Total 230 7.3 3.7d 3.2-4.2 1085 34.3 98.0d 92.3-104.0 1850 58.5 317.0d 302.4-332.0
NHW
Northern Plains 1686 5.0 4.9 4.7-5.2 8809 26.2 114.2 111.8-116.6 23,131 68.8 354.8 350.3-359.4
Alaska 111 8.8 4.6 3.8-5.5 450 35.9 108.5 98.6-119.1 694 55.3 411.9 381.2-444.4
Southern Plains 808 4.8 6.7 6.2-7.2 4521 27.1 148.8 144.5-153.3 11,333 68.0 435.3 427.3-443.4
Pacific Coast 2720 4.1 4.3 4.1-4.5 16,144 24.4 112.0 110.2-113.7 47,311 71.5 397.3 393.7-400.9
East 2358 4.7 5.9 5.6-6.1 12,572 25.0 130.8 128.5-133.1 35,331 70.3 398.1 393.9-402.3
Southwest 1095 3.8 4.3 4.1-4.6 7451 25.6 111.9 109.4-114.5 20,549 70.6 361.8 356.8-366.8
Total 8778 4.5 4.9 4.8-5.0 49,947 25.3 119.3 118.2-120.3 138,349 70.2 386.7 384.7-388.8
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program.
IHS indicates Indian Health Service; CI, confidence interval; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites.
a Percentages may not add to 100% because of rounding.
b Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups; Census P25-1130; see Day 199632).
c The AI/AN rate is statistically significantly higher than the NHW rate (P<.05).
d The AI/AN rate is statistically significantly lower than the NHW rate (P<.05).
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Columbian times. Many Native stories emphasize the
sacredness of the plant and its powers to heal if used
properly and to harm if used improperly. Traditional
tobacco mixes may include the Nicotiana plant, kin-
nick-kinnick, and other herbs. However, commercial
tobacco products, by virtue of convenience, are used
sometimes for ceremonial functions. Inhalation of
tobacco smoke during ceremonial use typically is
brief and does not occur every day; therefore, it
is unlikely to lead to lung cancer.
Data from 15 years of Behavioral Risk Factor Sur-
veillance System (BRFSS) surveys indicate that AI/AN
current smoking rates have not been declining.36,38-40
According to aggregate data from the 2000 through
2006 BRFSS, AI/AN respondents were more likely to
be currently smoking cigarettes (31.1%) than the
NHW population (22.8%).36 Current cigarette smoking
was highest in the Northern Plains (40.2%) and Alaska
(40%) and was lowest in the Southwest (21.1%).36 For
all racial and ethnic groups, data on current cigarette
smoking from the 2006 National Health Interview Sur-
vey show the highest rate among AI/ANs (26.9%), fol-
lowed by NHWs (22.6%), Native Hawaiian/Pacific
Islanders (22.5%), African Americans (21.8%), Hispa-
nics (14.5%), and Asians (10.7%).35
Although it is estimated that tobacco is a causal
factor in nearly 90% of lung cancers, other occupa-
tional and environmental exposures also are known
lung carcinogens. These include asbestos, radon, ar-
senic, and uranium mining.1 According to a 1999
Institute of Medicine report, an estimated 21,800
new diagnoses of lung cancer are related to radon
(14%) each year in the United States, which makes
radon the second leading cause of lung cancer
deaths after cigarette smoking.41 Other studies have
suggested a synergistic relation between radon expo-
sure and cigarette smoking that may increase the
risk of lung cancer to 6 to 10 times higher than
among nonsmokers.11,12,42 Radon gas occurs natu-
rally in small amounts in soils and rocks throughout
the United States. Radon can become trapped in
homes and other structures, creating the potential
for elevated exposure.43 The Environmental Protec-
tion Agency (EPA) has established 4 pico Curies per
liter (pCi/L) as the threshold above which action
should be taken to alter a structure to reduce radon
exposure.44 EPA maps of radon zones indicate that
homes in the part of the country with a high pro-
portion of AI/ANs contain high (4 pCi/L) or moder-
ate (2 pCi/L) levels of radon, which may contribute
to some cases of lung cancer among AI/ANs.45
Another form of exposure to radon is in the process
of uranium mining. This occupational exposure has
long been documented as a strong causal factor in
the development of lung cancer. In the Southwest,
many AI/AN males worked in uranium mines in the
1950s and 1960s; it has been demonstrated that this
is an important cause of lung cancer in a population
that historically has had a very low prevalence of
smoking.5,6 The Southwest region has had the low-
est lung cancer incidence rates, despite the exten-
sive exposure to uranium mining that occurred in
that region.
Other known risk factors for lung cancer may
include tuberculosis and chronic obstructive pulmo-
nary disease.46 Exposure to arsenic, chromium,
nickel, aromatic hydrocarbons, and ethers, most
commonly in an occupational setting, also may
increase the risk of lung cancer.47
The IHS patient registration database contains
records of individuals who are members of federally
recognized tribes, and linking these data with SEER
and NPCR registries corrected some of the misclassi-
fication of race for AI/ANs.26 Restricting the sample
to the CHSDA counties also contributed to improved
rate estimates, because AI/ANs in those counties are
more likely to be registered for care with the IHS,
and less misclassification has been noted in these
counties.20 Because misclassification of AI/AN race is
so common in both state and national data-
bases,18,48-51 these processes contributed to improved
descriptions of the lung cancer burden for AI/ANs.
Despite these improvements, there are some lim-
itations to the data. Because most analyses were re-
stricted to CHSDA counties, in which only 56% of
AI/ANs live and which tend to be located in more ru-
ral areas and Western states (Fig. 1), the results may
not be generalizable to all AI/ANs (or NHWs) in the
United States. In addition, the percentage of AI/ANs
residing in CHSDA counties varied greatly among the
6 IHS regions (Table 1). The percentage was particu-
larly low in the East region (13.1%), which may help to
explain the puzzling occurrence in this region of rela-
tively low lung cancer incidence rates and high preva-
lence estimates of cigarette smoking.36 Another
limitation is that IHS records capture only enrolled
members of recognized tribes who seek healthcare
from the IHS and, thus, do not include others who
may self-identify in the United States Census as AI/AN,
notably urban AI/ANs and those who are from tribes
not recognized by the federal government. Misclassifi-
cation is likely to be greatest in the Pacific Coast and
East regions, where the IHS has a relatively small pre-
sence and only serves a small percentage of AI/ANs.
To our knowledge, this is the most complete
accounting of lung cancer occurrence among AI/AN
to date and demonstrates the substantial differences
in the incidence of this deadly cancer among the var-
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ious AI/AN populations. Until the 1990s, most AI/
ANs were not included in areas that were covered by
high-quality, population-based cancer registries. Cur-
rently, the NPCR and SEER annually produce the
United States Cancer Statistics, covering 98% of
United States population.21 In fact, national rates of
lung cancer incidence for all races combined report-
edly were higher than had been noted before United
States Cancer Statistics availability.52 Although the
methods used for this analysis improved the comple-
teness of reporting cancers among AI/AN by correct-
ing for some of the misclassification of race, the
linkage protocols need to be continued. Furthermore,
additional linkages with tribal rosters that were not
included in the current efforts are needed to further
improve the misclassification of race in AI/AN popu-
lations.
In conclusion, lung cancer is a significant pro-
blem for a large portion of AI/AN populations, nota-
bly those who live in the Northern Plains states and
Alaska, where dramatic disparities in lung cancer
incidence rates exist between AI/AN and NHW popu-
lations. AI/ANs in these regions have high estimates
of smoking prevalence compared with NHWs36 as
well as high lung cancer incidence rates. The 7-fold
difference between the lowest and highest lung can-
cer rates (Southwest vs Northern Plains) likely
reflects in large part the strong association between
cigarette smoking and the development of lung can-
cer. Indeed, BRFSS and local survey data indicate
that AI/ANs in Alaska and the Plains use tobacco at
rates higher than any other racial or ethnic popula-
tion in the United States.39 Our study underscores
the need for aggressive tobacco control programs
within AI/AN populations and communities.
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